Export

Nilotinib
Essential medicine status
General description
Nilotinib is a BCR-ABL tyrosine kinase inhibitor used in treatment protocols for chronic myeloid leukaemia
INN
Nilotinib
Medicine type
Chemical agent
EML status history
First added in 2017 (TRS 1006) for Chronic myeloid leukaemia, NOS
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Oral > Solid: 150 mg capsule; 200 mg capsule